SEC Filings

Form DEF 14A
PROTAGONIST THERAPEUTICS, INC filed this Form DEF 14A on 04/18/2018
Document Outline
Entire Document (413.5 KB)
Subdocument 1 - DEF 14A - >DEF 14A
Page 1 - UNITED STATES
Page 2 - 7707 Gateway Blvd., Suite 140
Page 3 - 7707 Gateway Blvd., Suite 140
Page 4 - Beneficial Owner: Shares Registered in the Name of a Broker or Bank
Page 5 - Beneficial Owner: Shares Registered in the Name of Broker or Bank
Page 6 - Who is paying for this proxy solicitation?
Page 7 - How are votes counted?
Page 8 - PROPOSAL 1
Page 9 - William D. Waddill
Page 10 - Armen B. Shanafelt, Ph.D.
Page 11 - Dinesh V. Patel, Ph.D.
Page 12 - N/A
Page 13 - Audit Committee
Page 14 - Report of the Audit Committee of the Board of Directors
Page 15 - Compensation Committee Processes and Procedures
Page 16 - N/A
Page 17 - Compensation Committee Interlocks and Insider Participation
Page 18 - N/A
Page 19 - PROPOSAL 2
Page 20 - THE BOARD OF DIRECTORS RECOMMENDS
Page 21 - EXECUTIVE OFFICERS
Page 22 - SECURITY OWNERSHIP OF
Page 23 - N/A
Page 24 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 25 - EXECUTIVE COMPENSATION
Page 26 - NARRATIVE TO SUMMARY COMPENSATION TABLE
Page 27 - OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END
Page 28 - OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2017
Page 29 - OPTION EXERCISES
Page 30 - N/A
Page 31 - EQUITY COMPENSATION PLAN INFORMATION
Page 32 - TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION
Page 33 - N/A
Page 34 - HOUSEHOLDING OF PROXY MATERIALS
Page 35 - OTHER MATTERS
Page 36 - THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.